Role of mitochondria ROS generation in ethanol-induced NLRP3 inflammasome activation and cell death in astroglial cells.
- Authors
- Alfonso-Loeches, Silvia; Ureña-Peralta, Juan R; Morillo-Bargues, Maria José; Oliver-De La Cruz, Jorge; Guerri, Consuelo
- Year
- 2014
- Journal
- Frontiers in cellular neuroscience
- PMID
- 25136295
- DOI
- 10.3389/fncel.2014.00216
- PMCID
- PMC4118026
Toll-like receptors (TLRs) and NOD-like receptors (NLRs) are innate immunity sensors that provide an early/effective response to pathogenic or injury conditions. We have reported that ethanol-induced TLR4 activation triggers signaling inflammatory responses in glial cells, causing neuroinflammation and brain damage. However, it is uncertain if ethanol is able to activate NLRs/inflammasome in astroglial cells, which is the mechanism of activation, and whether there is crosstalk between both immune sensors in glial cells. Here we show that chronic ethanol treatment increases the co-localization of caspase-1 with GFAP(+) cells, and up-regulates IL-1β and IL-18 in the frontal medial cortex in WT, but not in TLR4 knockout mice. We further show that cultured cortical astrocytes expressed several inflammasomes (NLRP3, AIM2, NLRP1, and IPAF), although NLRP3 mRNA is the predominant form. Ethanol, as ATP and LPS treatments, up-regulates NLRP3 expression, and causes caspase-1 cleavage and the release of IL-1β and IL-18 in astrocytes supernatant. Ethanol-induced NLRP3/caspase-1 activation is mediated by mitochondrial (m) reactive oxygen species (ROS) generation because when using a specific mitochondria ROS scavenger, the mito-TEMPO (500 μM) or NLRP3 blocking peptide (4 μg/ml) or a specific caspase-1 inhibitor, Z-YVAD-FMK (10 μM), abrogates mROS release and reduces the up-regulation of IL-1β and IL-18 induced by ethanol or LPS or ATP. Confocal microscopy studies further confirm that ethanol, ATP or LPS promotes NLRP3/caspase-1 complex recruitment within the mitochondria to promote cell death by caspase-1-mediated pyroptosis, which accounts for ≈73% of total cell death (≈22%) and the remaining (≈25%) die by caspase-3-dependent apoptosis. Suppression of the TLR4 function abrogates most ethanol effects on NLRP3 activation and reduces cell death. These findings suggest that NLRP3 participates, in ethanol-induced neuroinflammation and highlight the NLRP3/TLR4 crosstalk in ethanol-induced brain injury.
Chronic ethanol intake increases caspase-1 activity in cortical astroglial cells of TLR4 mice. (A–D) Confocal images illustrate the co-localization of caspase-1 (red) with GFAP (green) in the cortex area (E) of TLR4+/+ (A,B) and TLR4-/- (C,D) mice (arrows indicate co-localization of the Casp-1 and GFAP-positive cells). (F) Confocal negative controls, in the absence of primary antibodies. We used four independent biological replicates from each experimental condition. Scale bar: 75 μm. (G) The quantitative analysis shows the percentage of the increased number of Casp-1/GFAP-positive co-localized cells in the cortices of ethanol-treated WT mice in relation to the untreated control mice. Non-significant changes were observed for the treated/untreated TLR4-/- (TLR4-KO) mice. (H) Caspase-1 enzymatic activity was determined in the brain cortex. (I,J) The analysis of the IL-1β and IL-18 cytokines in the cortical homogenates of TLR4 mice was conducted by ELISA. Values represent the [mean ± SEM] of at least six to eight individual experiments.*p < 0.05, **p < 0.01 (Mann–Whitney U non-parametric test or a Student’s t-test).
Astrocytes in primary culture expresses high levels of NLRP3 mRNA. (A) mRNA expression of NLRP3, AIM2, NLRP1, and IPAF inflammasomes in cultured astrocytes evaluated by RT-PCR. (B) Ethanol treatment (10 and 50 mM) for 24 h up-regulates the NLRP3 mRNA levels in the cultured astrocytes from TLR4 mice. We used n = 5–7 independent experiments and ratios were normalized with the PPIA housekeeping gene. Bars represent the [mean ±SEM]. *p < 0.05, **p < 0.01, ***p < 0.001 (Mann–Whitney U non-parametric test or a Student’s t-test). (C) Immuno-fluorescence of NLRP3 (green) and GFAP- (red) co-localization in the astrocytes from TLR4 and TLR4-knockout mice. Scale bar 20 μm.
Ethanol treatment activates the NLRP3 inflammasome complex in cultured astrocytes from TLR4-WT mice. (A) Western blot analysis shows the NLRP3 and p10/caspase-1 active cleavage (the initiator caspase in pyroptosis) protein levels in the LPS-, ATP-, and ethanol- (10 and 50 mM) treated astrocytes. (B) We show ASC oligomerization and quantification of the ASC dimer by densitometry. Cells were lysed, pelleted by centrifugation and incubated with DSS for 30 min. The cross-linked pellets were resuspended in SDS sample buffer, and proteins were separated using 12% SDS-PAGE and Western blotted with anti-mouse ASC antibodies as described under Section “Material and Methods.” The presence of dimers and trimers was observed in the ATP-, LPS-, or ethanol-treated astrocytes correlating with a significative up-regulation of ASC dimers. (C) Cell lysates were collected and co-immunoprecipitated with the NLRP3 Ab (IP), and the immune complexes were detected by Western blot with Caspase-1 (IB). We show the presence of the p45 caspase-1 precursor and the active p20/p10 Caspase-1 in treated/untreated astrocytes. The mouse IgG was used as a negative control. (D) ELISA measured determined the IL-1β and IL-18 levels in the supernatant of the astrocytes treated with LPS, ATP and ethanol (10 and 50 mM) after 24 h. Non-significant differences were observed between the treated or non-treated TLR4-KO astrocytes. Values represent the mean ± SEM of 3–9 individual experiments. #p < 0.06, *p < 0.05, **p < 0.01, ***p < 0.001 (Mann–Whitney U non-parametric test or a Student’s t-test).
The ethanol-induced mitochondria ROS production level measured by MitoSOX Red fluorescence intensity. (A) A flow cytometry analysis shows that the ATP or LPS or ethanol (10 and 50 mM) treatments increased mROS generation in the WT astrocytes. Incubation with Z-YVAD-FMK, Z-VAD-FMK, the NLRP3 blocking peptide or Mito-TEMPO before and during treatments notably reduces mROS generation activation in WT astrocytes. (B) No significant changes in mROS generation were observed in the TLR4-KO-astrocytes incubated with the same inhibitors and treatments as used in the TLR4-astrocytes. Bars represent the (mean ± SEM) of 4–12 individual experiments. *p < 0.05, **p < 0.01, ***p < 0.001 (one-way ANOVA followed by a Dunnett’s Multiple Comparison Test or a Student’s t-test).
Ethanol enhances the production of IL-18 and IL-1β in WT astroglial cells. (A,B) Graphs represent the levels of IL-18 (A) and IL-1β (B) measured in the supernatant medium of the WT and TLR4-KO astrocytes treated with ATP, LPS or ethanol (10 and 50 mM) for 24 h. Incubation with Z-YVAD-FMK, Z-VAD-FMK, the NLRP3 blocking peptide or Mito-TEMPO, along with the different treatments, reduces, or even abolishes, the up-regulation of the cytokine release. No changes in the levels of cytokines were noted in the supernatant medium for the TLR4-KO-astrocytes for any of the treatments and inhibitors used, except for the Mito-TEMPO treatment at the IL-18 released levels. Bars represent the (mean ± SEM) expressed as a percentage (%) of 6–10 individual experiments. *p < 0.05, **p < 0.01, ***p < 0.001 (two-way ANOVA with post hoc Bonferroni’s correction).
Confocal images of NLRP3/caspase-1 co-localization within mitochondria of the astrocytes treated with ethanol, ATP, or LPS. Microphotographs show that the ATP, LPS, or ethanol (10 mM) treatments promote the co-localization of NLRP3 inflammasome (blue) with active caspase-1 (green) within mitochondria (red) in the WT-astrocytes when compared with the untreated control astrocytes (A). Astrocytes treated with Z-VAD-FMK (B) and with Mito-TEMPO (C) treatments do not induce caspase-1 activation in both WT and TLR4-KO astrocytes. We performed at least three independent experiments under each experimental condition. Representative pictures are presented.
Activation of the NLRP3 inflammasome complex triggers pyroptosis and apoptosis in ethanol-induced astroglial cells. (A) Bars show the percentage of cell dead by pyroptosis, necrosis and apoptosis in astrocytes treated for 24 h with ATP, LPS, and ethanol (10 and 50 mM) evaluated by an In Cell Analyzer. Approximately 1000–5000 cells were analyzed/experimental condition. Bars represent the (mean ± SD). (B) LDH activity in the supernatant astrocytes was measured with different treatments. Bars represent the (mean ± SEM) of at least 6–10 individual experiments. *p < 0.05, **p < 0.01 (Mann–Whitney U non-parametric test).
Ethanol can also induce the apoptosome formation in astrocytes. (A) The Western blot analyses of Apaf-1, the active fragments from caspase-9 (37 kDa) and caspase-3 (17 kDa), in the astrocytes treated with ATP (5 μM) or ethanol (10 and 50 mM). Bars represent the (mean ± SEM) of at least 6–10 individual experiments. *p < 0.05, **p < 0.01 (Mann–Whitney U non-parametric test or a Student’s t-test). (B) The percentage of apoptosis in the astrocytes incubated with ATP or ethanol (10 mM, 50 mM) for 24 h was assessed by a TUNEL assay in the WT and TLR4-KO astrocytes. Scale bar: 20 μm. Arrowheads show different apoptotic processes, blebbing and nuclei condensation. Asterisk show positive TUNEL cells. Bars represent the (mean ± SEM) of three individual experiments. *p < 0.05, **p < 0.01 (two-way ANOVA with post hoc Bonferroni’s correction).
No entities extracted from this document yet.
No uploaded files.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| Alfonso-LoechesS.Pascual-LucasM.BlancoA. M.Sanchez-VeraI.GuerriC. (2010). Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. J. Neurosci. 30 8285–8295 10.1523/JNEUROSCI.0976-10.201020554880PMC6634595 | — | — | — |
| Alfonso-LoechesS.PascualM.Gomez-PinedoU.Pascual-LucasM.Renau-PiquerasJ.GuerriC. (2012). Toll-like receptor 4 participates in the myelin disruptions associated with chronic alcohol abuse. Glia 60 948–964 10.1002/glia.2232722431236 | — | — | — |
| ArlehamnC. S.PetrilliV.GrossO.TschoppJ.EvansT. J. (2010). The role of potassium in inflammasome activation by bacteria. J. Biol. Chem. 285 10508–10518 10.1074/jbc.M109.06729820097760PMC2856258 | — | — | — |
| BeckerC. E.O’NeillL. A. (2007). Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs. Semin. Immunopathol. 29 239–248 10.1007/s00281-007-0081-417805544 | — | — | — |
| BlancoA. M.Perez-AragoA.Fernandez-LizarbeS.GuerriC. (2008). Ethanol mimics ligand-mediated activation and endocytosis of IL-1RI/TLR4 receptors via lipid rafts caveolae in astroglial cells. J. Neurochem. 106 625–639 10.1111/j.1471-4159.2008.05425.x18419766 | — | — | — |
| BlancoA. M.VallesS. L.PascualM.GuerriC. (2005). Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes. J. Immunol. 175 6893–6899 10.4049/jimmunol.175.10.689316272348 | — | — | — |
| De NardoD.LatzE. (2011). NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol. 32 373–379 10.1016/j.it.2011.05.00421733753PMC3151541 | — | — | — |
| DoitshG.GallowayN. L.GengX.YangZ.MonroeK. M.ZepedaO. (2014). Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505 509–514 10.1038/nature1294024356306PMC4047036 | — | — | — |
| DostertC.GuardaG.RomeroJ. F.MenuP.GrossO.TardivelA. (2009). Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS ONE 4:e6510 10.1371/journal.pone.0006510PMC271497719652710 | — | — | — |
| FarinaC.AloisiF.MeinlE. (2007). Astrocytes are active players in cerebral innate immunity. Trends Immunol. 28 138–145 10.1016/j.it.2007.01.00517276138 | — | — | — |
| Fernandes-AlnemriT.AlnemriE. S. (2008). Assembly, purification, and assay of the activity of the ASC pyroptosome. Methods Enzymol. 442 251–270 10.1016/S0076-6879(08)01413-418662574 | — | — | — |
| Fernandes-AlnemriT.WuJ.YuJ. W.DattaP.MillerB.JankowskiW. (2007). The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 14 1590–1604 10.1038/sj.cdd.440219417599095PMC3345951 | — | — | — |
| Fernandez-LizarbeS.PascualM.GuerriC. (2009). Critical role of TLR4 response in the activation of microglia induced by ethanol. J. Immunol. 183 4733–4744 10.4049/jimmunol.080359019752239 | — | — | — |
| FranklinK. B. J.PaxinosG. (1997). The Mouse Brain in Stereotaxic Coordinates. San Diego: Academic Press | — | — | — |
| Goldbach-ManskyR.DaileyN. J.CannaS. W.GelabertA.JonesJ.RubinB. I. (2006). Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition. N. Engl. J. Med. 355 581–592 10.1056/NEJMoa05513716899778PMC4178954 | — | — | — |
| GonzalezA.ParienteJ. A.SalidoG. M. (2007). Ethanol stimulates ROS generation by mitochondria through Ca2+ mobilization and increases GFAP content in rat hippocampal astrocytes. Brain Res. 1178 28–37 10.1016/j.brainres.2007.08.04017888892 | — | — | — |
| GrossO.ThomasC. J.GuardaG.TschoppJ. (2011). The inflammasome: an integrated view. Immunol. Rev. 243 136–151 10.1111/j.1600-065X.2011.01046.x21884173 | — | — | — |
| HanamsagarR.TorresV.KielianT. (2012). Inflammasome activation and IL-1β/IL-18 processing are influenced by distinct pathways in microglia. J. Neurochem. 119 736–748 10.1111/j.1471-4159.2011.07481.x21913925PMC3202981 | — | — | — |
| HenekaM. T.KummerM. P.StutzA.DelekateA.SchwartzS.Vieira-SaeckerA. (2013). NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature 493 674–678 10.1038/nature1172923254930PMC3812809 | — | — | — |
| HornungV.LatzE. (2010). Critical functions of priming and lysosomal damage for NLRP3 activation. Eur. J. Immunol. 40 620–623 10.1002/eji.20094018520201015PMC3893565 | — | — | — |
| JhaS.SrivastavaS. Y.BrickeyW. J.IoccaH.ToewsA.MorrisonJ. P. (2010). The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J. Neurosci. 30 15811–15820 10.1523/JNEUROSCI.4088-10.201021106820PMC6633756 | — | — | — |
| JhaS.TingJ. P. (2009). Inflammasome-associated nucleotide-binding domain, leucine-rich repeat proteins and inflammatory diseases. J. Immunol. 183 7623–7629 10.4049/jimmunol.090242520007570PMC3666034 | — | — | — |
| JinC.FlavellR. A. (2010). Molecular mechanism of NLRP3 inflammasome activation. J. Clin. Immunol. 30 628–631 10.1007/s10875-010-9440-320589420 | — | — | — |
| JulianaC.Fernandes-AlnemriT.KangS.FariasA.QinF.AlnemriE. S. (2012). Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J. Biol. Chem. 287 36617–36622 10.1074/jbc.M112.40713022948162PMC3476327 | — | — | — |
| KahlenbergJ. M.LundbergK. C.KertesyS. B.QuY.DubyakG. R. (2005). Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis. J. Immunol. 175 7611–7622 10.4049/jimmunol.175.11.761116301671 | — | — | — |
| LampronA.ElaliA.RivestS. (2013). Innate immunity in the CNS: redefining the relationship between the CNS and Its environment. Neuron 78 214–232 10.1016/j.neuron.2013.04.00523622060 | — | — | — |
| LatzE.XiaoT. S.StutzA. (2013). Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13 397–411 10.1038/nri345223702978PMC3807999 | — | — | — |
| LippaiD.BalaS.CsakT.Kurt-JonesE. A.SzaboG. (2013). Chronic alcohol-induced microRNA-155 contributes to neuroinflammation in a TLR4-dependent manner in mice. PLoS ONE 8:e70945 10.1371/journal.pone.0070945PMC373977223951048 | — | — | — |
| LuA.MagupalliV. G.RuanJ.YinQ.AtianandM. K.VosM. R. (2014). Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 156 1193–1206 10.1016/j.cell.2014.02.00824630722PMC4000066 | — | — | — |
| Manzo-AvalosS.Saavedra-MolinaA. (2010). Cellular and mitochondrial effects of alcohol consumption. Int. J. Environ. Res. Public Health 7 4281–4304 10.3390/ijerph712428121318009PMC3037055 | — | — | — |
| MariathasanS.MonackD. M. (2007). Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat. Rev. Immunol. 7 31–40 10.1038/nri199717186029 | — | — | — |
| MartinonF. (2007). Orchestration of pathogen recognition by inflammasome diversity: variations on a common theme. Eur. J. Immunol. 37 3003–3006 10.1002/eji.20073787117960661 | — | — | — |
| MiaoE. A.RajanJ. V.AderemA. (2011). Caspase-1-induced pyroptotic cell death. Immunol. Rev. 243 206–214 10.1111/j.1600-065X.2011.01044.x21884178PMC3609431 | — | — | — |
| MinanaR.ClimentE.BarettinoD.SeguiJ. M.Renau-PiquerasJ.GuerriC. (2000). Alcohol exposure alters the expression pattern of neural cell adhesion molecules during brain development. J. Neurochem. 75 954–964 10.1046/j.1471-4159.2000.0750954.x10936176 | — | — | — |
| MinkiewiczJ.de Rivero VaccariJ. P.KeaneR. W. (2013). Human astrocytes express a novel NLRP2 inflammasome. Glia 61 1113–1121 10.1002/glia.2249923625868 | — | — | — |
| MorizotB. (2012). Chance: from metaphysical principle to explanatory concept. The idea of uncertainty in a natural history of knowledge. Prog. Biophys. Mol. Biol. 110 54–60 10.1016/j.pbiomolbio.2012.04.00722575223 | — | — | — |
| NakahiraK.HaspelJ. A.RathinamV. A.LeeS. J.DolinayT.LamH. C. (2011). Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12 222–230 10.1038/ni.198021151103PMC3079381 | — | — | — |
| NevenB.CallebautI.PrieurA. M.FeldmannJ.BodemerC.LeporeL. (2004). Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 103 2809–2815 10.1182/blood-2003-07-253114630794 | — | — | — |
| ParajuliB.SonobeY.HoriuchiH.TakeuchiH.MizunoT.SuzumuraA. (2013). Oligomeric amyloid β induces IL-1β processing via production of ROS: implication in Alzheimer’s disease. Cell Death Dis. 4:e975 10.1038/cddis.2013.503PMC387757024357806 | — | — | — |
| PetrilliV.DostertC.MuruveD. A.TschoppJ. (2007). The inflammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 19 615–622 10.1016/j.coi.2007.09.00217977705 | — | — | — |
| PfafflM. W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45 10.1093/nar/29.9.e45PMC5569511328886 | — | — | — |
| PittockS. J.LucchinettiC. F. (2007). The pathology of MS: new insights and potential clinical applications. Neurologist 13 45–56 10.1097/01.nrl.0000253065.31662.3717351524 | — | — | — |
| QuY.FranchiL.NunezG.DubyakG. R. (2007). Nonclassical IL-1 β secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J. Immunol. 179 1913–1925 10.4049/jimmunol.179.3.191317641058 | — | — | — |
| SchroderK.TschoppJ. (2010). The inflammasomes. Cell 140 821–832 10.1016/j.cell.2010.01.04020303873 | — | — | — |
| SchroderK.ZhouR.TschoppJ. (2010). The NLRP3 inflammasome: a sensor for metabolic danger? Science 327 296–300 10.1126/science.118400320075245 | — | — | — |
| SheedyF. J.GrebeA.RaynerK. J.KalantariP.RamkhelawonB.CarpenterS. B. (2013). CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat. Immunol. 14 812–820 10.1038/ni.263923812099PMC3720827 | — | — | — |
| ShimadaK.CrotherT. R.ArditiM. (2012a). Innate immune responses to Chlamydia pneumoniae infection: role of TLRs, NLRs, and the inflammasome. Microbes Infect. 14 1301–1307 10.1016/j.micinf.2012.08.00422985781PMC3511600 | — | — | — |
| ShimadaK.CrotherT. R.KarlinJ.DagvadorjJ.ChibaN.ChenS. (2012b). Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36 401–414 10.1016/j.immuni.2012.01.00922342844PMC3312986 | — | — | — |
| SospedraM.MartinR. (2005). Antigen-specific therapies in multiple sclerosis. Int. Rev. Immunol. 24 393–413 10.1080/0883018050037125616318988 | — | — | — |
| SubramanianN.NatarajanK.ClatworthyM. R.WangZ.GermainR. N. (2013). The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell 153 348–361 10.1016/j.cell.2013.02.05423582325PMC3632354 | — | — | — |
| SutterwalaF. S.OguraY.SzczepanikM.Lara-TejeroM.LichtenbergerG. S.GrantE. P. (2006). Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24 317–327 10.1016/j.immuni.2006.02.00416546100 | — | — | — |
| TanM. S.YuJ. T.JiangT.ZhuX. C.TanL. (2013). The NLRP3 inflammasome in Alzheimer’s disease. Mol. Neurobiol. 48 875–882 10.1007/s12035-013-8475-x23686772 | — | — | — |
| TezelG.YangX.LuoC.CaiJ.PowellD. W. (2012). An astrocyte-specific proteomic approach to inflammatory responses in experimental rat glaucoma. Invest. Ophthalmol. Vis. Sci. 53 4220–4233 10.1167/iovs.11-910122570341PMC3392010 | — | — | — |
| TingJ. P.DavisB. K. (2005). CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu. Rev. Immunol. 23 387–414 10.1146/annurev.immunol.23.021704.11561615771576 | — | — | — |
| TriantafilouK.HughesT. R.TriantafilouM.MorganB. P. (2013). The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation. J. Cell Sci. 126 2903–2913 10.1242/jcs.12438823613465 | — | — | — |
| TschoppJ.SchroderK. (2010). NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 10 210–215 10.1038/nri272520168318 | — | — | — |
| TsengW. A.TheinT.KinnunenK.LashkariK.GregoryM. S.D’AmoreP. A. (2013). NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 54 110–120 10.1167/iovs.12-1065523221073PMC3544415 | — | — | — |
| YuanX.ZhouY.WangW.LiJ.XieG.ZhaoY. (2013). Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production. Cell Death Dis. 4:e794 10.1038/cddis.2013.334PMC378919224030146 | — | — | — |
| ZhouR.YazdiA. S.MenuP.TschoppJ. (2011). A role for mitochondria in NLRP3 inflammasome activation. Nature 469 221–225 10.1038/nature0966321124315 | — | — | — |
| ZouJ.CrewsF. T. (2012). Inflammasome-IL-1β signaling mediates ethanol inhibition of hippocampal neurogenesis. Front. Neurosci. 6:77 10.3389/fnins.2012.00077PMC336280522661925 | — | — | — |
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Alcohol drinking sex-dependently regulates interleukin-1 pro-inflammatory signaling in the prefrontal cortex of mice and rhesus macaques. | Liss A et al. | — | 2026 | → |
| Chinese Herbal Medicines for Diabetic Cardio-Cerebrovascular Diseases: Key Bioactive Metabolites and Action Mechanisms. | Su Y et al. | — | 2026 | → |
| Immunomodulatory effects of mesenchymal stem cell-derived extracellular vesicles on NLRP3 inflammasome activation in the adult mouse brain after chronic ethanol exposure. | Mellado S et al. | — | 2026 | → |
| T-2 toxin exacerbates chondrocyte extracellular matrix degradation potentially through YAP/NLRP3/GSDMD-mediated pyroptosis. | Li H et al. | — | 2026 | → |
| Adolescent trauma and alcohol: increased risk for severe head injury and organ dysfunction-insights from the TraumaRegister DGU<sup>®</sup>. | Hörauf JA et al. | — | 2025 | → |
| Beclin1 regulates yak endometrial inflammation and TLR4/NF-κB signaling pathway through autophagy/non-autophagy function. | Ma W et al. | — | 2025 | → |
| Carbon quantum dots amplify beneficial effects of EGCG against neural injuries by NLRP3 inflammasome after intracerebral hemorrhage. | Xiao M et al. | — | 2025 | → |
| Ethanol-Induced Depression: Exploring the Underlying Molecular Mechanisms. | Mashayekhi-Sardoo H et al. | — | 2025 | → |
| Ethanol modulates astrocyte activation and neuroinflammation via miR-339/NLRP6 inflammasome signaling. | Singh S et al. | — | 2025 | → |
| Glymphatic system dysfunction in alcohol use disorder: Current understanding and future directions. | Lin JY et al. | — | 2025 | → |
| Idiopathic Pulmonary Fibrosis Caused by Damaged Mitochondria and Imbalanced Protein Homeostasis in Alveolar Epithelial Type II Cell. | Dong Z et al. | — | 2025 | → |
| Inhibition Effects of Patchouli Alcohol, Carvacrol, p-Cymene, Eucalyptol and Their Formulations Against Influenza Virus Pneumonia Through TLR4/NF-κB/NLRP3 Signaling Pathway. | Lv R et al. | — | 2025 | → |
| Mechanistic Insights on Cardioprotective Properties of Ursolic Acid: Regulation of Mitochondrial and Non-mitochondrial Pathways. | Roudi HS et al. | — | 2025 | → |
| Neurological alterations in adult female rats developmentally exposed to a glyphosate-based herbicide: Potential role of the immune system. | Gallegos CE et al. | — | 2025 | → |
| NLRP3 inflammasome in neuroinflammation and central nervous system diseases. | Xu W et al. | — | 2025 | → |
| Programmed Aggregation of Lipidated Nitrobenzoselenadiazole as a Photo-Activatable Pyroptosis Inducer. | An JM et al. | — | 2025 | → |
| Purinergic and extracellular vesicle signaling in alcohol-induced blood-brain barrier breakdown and neuroimmune activation. | Togre NS et al. | — | 2025 | → |
| Pyroptosis; igniting neuropsychiatric disorders from mild depression to aging-related neurodegeneration. | Hushmandi K et al. | — | 2025 | → |
| SMP30 Attenuates Lens Epithelial Cells Pyroptosis of Cataract via the Downregulation of p-STAT3. | Liang Y et al. | — | 2025 | → |
| Suppression of NF-κB/NLRP3 by nanoligomer therapy mitigates ethanol and advanced age-related neuroinflammation. | Anton PE et al. | — | 2025 | → |
| The Effect of Metformin on Astrocytes in Parkinson's Disease: Challenges and Opportunities. | Al-Kuraishy HM et al. | — | 2025 | → |
| The emerging role of mesenchymal stem cell-derived extracellular vesicles to ameliorate hippocampal NLRP3 inflammation induced by binge-like ethanol treatment in adolescence. | Mellado S et al. | — | 2025 | → |
| The oral microbiome-redox-inflammation axis in neurodegeneration: mechanistic insights and therapeutic perspectives. | Tien Vo TT et al. | — | 2025 | → |
| Thiamine Deficiency and Neuroinflammation Are Important Contributors to Alcohol Use Disorder. | Kalapatapu N et al. | — | 2025 | → |
| Acute Genetic Damage Induced by Ethanol and Corticosterone Seems to Modulate Hippocampal Astrocyte Signaling. | Reyes-Ábalos AL et al. | — | 2024 | → |
| AIM2 inflammasome: A potential therapeutic target in ischemic stroke. | Fu R et al. | — | 2024 | → |
| Chrysophanol attenuates cognitive impairment, neuroinflammation, and oxidative stress by TLR4/ NFκB -Nrf2/HO-1 signaling in ethanol induced neurodegeneration | Khan JZ et al. | — | 2024 | — |
| Crosstalk between autophagy and ferroptosis mediate injury in ischemic stroke by generating reactive oxygen species. | Zhang XY et al. | — | 2024 | → |
| Cx43 hemichannels and panx1 channels contribute to ethanol-induced astrocyte dysfunction and damage. | Gómez GI et al. | — | 2024 | → |
| Dexmedetomidine enhances Mitophagy via PINK1 to alleviate hippocampal neuronal Pyroptosis and improve postoperative cognitive dysfunction in elderly rat. | Chen Y et al. | — | 2024 | → |
| Embryonic ethanol exposure induces oxidative stress and inflammation in zebrafish model: A dose-dependent study. | Raghul Kannan S et al. | — | 2024 | → |
| Erythropoietin alleviates astrocyte pyroptosis by targeting the miR-325-3p/Gsdmd axis in rat spinal cord injury. | Shan W et al. | — | 2024 | → |
| Ethanol causes non-communicable disease through activation of NLRP3 inflammasome: a review on mechanism of action and potential interventions. | Liu R et al. | — | 2024 | → |
| Golgi apparatus regulated pyroptosis through the miR-32-5p/Golga7/NLRP3 axis in chicken splenic lymphocytes exposure to ammonia. | Liu J et al. | — | 2024 | → |
| Hemichannels contribute to mitochondrial Ca<sup>2+</sup> and morphology alterations evoked by ethanol in astrocytes. | Alvear TF et al. | — | 2024 | → |
| Neutrophil membrane-derived nanoparticles protect traumatic brain injury via inhibiting calcium overload and scavenging ROS. | Li H et al. | — | 2024 | → |
| "Other Than NLRP3" Inflammasomes: Multiple Roles in Brain Disease. | Chiarini A et al. | — | 2024 | → |
| PRDX6-iPLA2 aggravates neuroinflammation after ischemic stroke via regulating astrocytes-induced M1 microglia. | Peng L et al. | — | 2024 | → |
| Role of NLRP3 in Parkinson's disease: Specific activation especially in dopaminergic neurons. | Yu J et al. | — | 2024 | → |
| Unraveling the Triad: Hypoxia, Oxidative Stress and Inflammation in Neurodegenerative Disorders. | Chand Dakal T et al. | — | 2024 | → |
| Unveiling the role of astrogliosis in Alzheimer's disease Pathology: Insights into mechanisms and therapeutic approaches. | Paidlewar M et al. | — | 2024 | → |
| 18 kDa Translocator Protein TSPO Is a Mediator of Astrocyte Reactivity. | Tournier BB et al. | — | 2023 | → |
| ACSS2 gene variants determine kidney disease risk by controlling de novo lipogenesis in kidney tubules. | Mukhi D et al. | — | 2023 | → |
| Acute Ethanol Modulates Synaptic Inhibition in the Basolateral Amygdala via Rapid NLRP3 Inflammasome Activation and Regulates Anxiety-Like Behavior in Rats. | Munshi S et al. | — | 2023 | → |
| Advances on the early cellular events occurring upon exposure of human macrophages to aluminum oxyhydroxide adjuvant. | Masson JD et al. | — | 2023 | → |
| Alcohol induces ER stress and apoptosis by inducing oxidative stress and disruption of calcium homeostasis in glial cells. | Sushma et al. | — | 2023 | → |
| BDE-47 flame retardant exposure induces microglial pyroptosis and cognitive deficits by activating the mtROS-NLRP3 axis via Sirt3 downregulation and is salvaged by honokiol. | Wang D et al. | — | 2023 | → |
| Broadening Horizons: Exploring mtDAMPs as a Mechanism and Potential Intervention Target in Cardiovascular Diseases. | Luan Y et al. | — | 2023 | → |
| Cerebellar Transcriptomic Analysis in a Chronic plus Binge Mouse Model of Alcohol Use Disorder Demonstrates Ethanol-Induced Neuroinflammation and Altered Glial Gene Expression. | Holloway KN et al. | — | 2023 | → |
| Detrimental Effects of Alcohol-Induced Inflammation on Brain Health: From Neurogenesis to Neurodegeneration. | Anand SK et al. | — | 2023 | → |
| Dexmedetomidine Inhibits Parthanatos in Cardiomyocytes and in Aortic Banded Mice by the ROS-Mediated NLRP3 Inflammasome Activation. | Wang L et al. | — | 2023 | → |
| Ethanol-induced cerebellar transcriptomic changes in a postnatal model of fetal alcohol spectrum disorders: Focus on disease onset. | Holloway KN et al. | — | 2023 | → |
| Glaucomatous optic neuropathy: Mitochondrial dynamics, dysfunction and protection in retinal ganglion cells. | Ju WK et al. | — | 2023 | → |
| Hexokinase dissociation from mitochondria promotes oligomerization of VDAC that facilitates NLRP3 inflammasome assembly and activation. | Baik SH et al. | — | 2023 | → |
| Is Drp1 a link between mitochondrial dysfunction and inflammation in Alzheimer's disease? | Sbai O et al. | — | 2023 | → |
| Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities. | Réus GZ et al. | — | 2023 | → |
| N-Acetylcysteine normalizes brain oxidative stress and neuroinflammation observed after protracted ethanol abstinence: a preclinical study in long-term ethanol-experienced male rats. | Fernández-Rodríguez S et al. | — | 2023 | → |
| Potential regulatory effects of stem cell exosomes on inflammatory response in ischemic stroke treatment. | Chen N et al. | — | 2023 | → |
| Research Advances of Mitochondrial Dysfunction in Perioperative Neurocognitive Disorders. | Chen M et al. | — | 2023 | → |
| Serum/glucocorticoid-inducible kinase 1 deficiency induces NLRP3 inflammasome activation and autoinflammation of macrophages in a murine endolymphatic hydrops model. | Zhang DG et al. | — | 2023 | → |
| Targeting NLRP3 inflammasome for neurodegenerative disorders. | Yao J et al. | — | 2023 | → |
| The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases. | Davis SE et al. | — | 2023 | → |
| Age-Associated Glia Remodeling and Mitochondrial Dysfunction in Neurodegeneration: Antioxidant Supplementation as a Possible Intervention. | Picca A et al. | — | 2022 | → |
| Alcohol use disorder as a potential risk factor for COVID-19 severity: A narrative review. | Forsyth CB et al. | — | 2022 | → |
| Ameliorative effect of scutellarin on acute alcohol brain injury in mice. | Zhang T et al. | — | 2022 | → |
| Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the <i>Substantia Nigra</i> of Male Rodents and Primary Mesencephalic Cultures. | Quijano A et al. | — | 2022 | → |
| ChemR23 signaling ameliorates cognitive impairments in diabetic mice via dampening oxidative stress and NLRP3 inflammasome activation. | Zhang J et al. | — | 2022 | → |
| Chronic glucocorticoid exposure accelerates Aβ generation and neurotoxicity by activating calcium-mediated CN-NFAT1 signaling in hippocampal neurons in APP/PS1 mice. | Ding S et al. | — | 2022 | → |
| Crosstalk Between the Oxidative Stress and Glia Cells After Stroke: From Mechanism to Therapies. | Zhu G et al. | — | 2022 | → |
| Dental pulp stem cell-derived exosomes suppress M1 macrophage polarization through the ROS-MAPK-NFκB P65 signaling pathway after spinal cord injury. | Liu C et al. | — | 2022 | → |
| Downregulation of ROCK2 attenuates alcohol-induced inflammation and oxidative stress in astrocytes. | Li X et al. | — | 2022 | → |
| Effects of Natural Polyphenols on Oxidative Stress-Mediated Blood-Brain Barrier Dysfunction. | Kim Y et al. | — | 2022 | → |
| Hypobaric hypoxia triggers pyroptosis in the retina via NLRP3 inflammasome activation. | Xin X et al. | — | 2022 | → |
| Immunologic aspects of migraine: A review of literature. | Salahi M et al. | — | 2022 | → |
| Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases. | Lin MM et al. | — | 2022 | → |
| Oridonin attenuates LPS-induced early pulmonary fibrosis by regulating impaired autophagy, oxidative stress, inflammation and EMT. | Yang H et al. | — | 2022 | → |
| Oxidative Stress and Extracellular Matrix Remodeling Are Signature Pathways of Extracellular Vesicles Released upon Morphine Exposure on Human Brain Microvascular Endothelial Cells. | Vujić T et al. | — | 2022 | → |
| PM<sub>2.5</sub> exposure inducing ATP alteration links with NLRP3 inflammasome activation. | Zeng X et al. | — | 2022 | → |
| Polysaccharide extract from Isatidis Radix inhibits multiple inflammasomes activation and alleviate gouty arthritis. | Ren L et al. | — | 2022 | → |
| Pyroptosis in spinal cord injury. | Yin J et al. | — | 2022 | → |
| Regulation of oxidative stress and inflammatory responses in human retinal pigment epithelial cells. | Harju N | — | 2022 | → |
| Supramolecular organizing centers at the interface of inflammation and neurodegeneration. | Sušjan-Leite P et al. | — | 2022 | → |
| The BCL2/BAX/ROS pathway is involved in the inhibitory effect of astragaloside IV on pyroptosis in human umbilical vein endothelial cells. | Su Y et al. | — | 2022 | → |
| Therapeutic targeting of microglia mediated oxidative stress after neurotrauma. | Smith AN et al. | — | 2022 | → |
| VX-765 ameliorates renal injury and fibrosis in diabetes by regulating caspase-1-mediated pyroptosis and inflammation. | Wen S et al. | — | 2022 | → |
| Agmatine Alleviates Epileptic Seizures and Hippocampal Neuronal Damage by Inhibiting Gasdermin D-Mediated Pyroptosis. | Li X et al. | — | 2021 | → |
| Anti-inflammatory effects of paeoniflorin caused by regulation of the hif1a/miR-210/caspase1/GSDMD signaling pathway in astrocytes: a novel strategy for hypoxia-induced brain injury in rats. | Jiang Z et al. | — | 2021 | → |
| A targeted polypeptide-based nanoconjugate as a nanotherapeutic for alcohol-induced neuroinflammation. | Cuesta CM et al. | — | 2021 | → |
| Effects of Resvega on Inflammasome Activation in Conjunction with Dysfunctional Intracellular Clearance in Retinal Pigment Epithelial (RPE) Cells. | Bhattarai N et al. | — | 2021 | → |
| Elamipretide (SS-31) Improves Functional Connectivity in Hippocampus and Other Related Regions Following Prolonged Neuroinflammation Induced by Lipopolysaccharide in Aged Rats. | Liu Y et al. | — | 2021 | → |
| Enriched Environment Attenuates Pyroptosis to Improve Functional Recovery After Cerebral Ischemia/Reperfusion Injury. | Liu J et al. | — | 2021 | → |
| Ethanol, neurosteroids and cellular stress responses: Impact on central nervous system toxicity, inflammation and autophagy. | Fujii C et al. | — | 2021 | → |
| Hypoxia and Porphyromonas gingivalis-lipopolysaccharide synergistically induce NLRP3 inflammasome activation in human gingival fibroblasts. | Yang K et al. | — | 2021 | → |
| Knockdown of dual oxidase 1 suppresses activin A-induced fibrosis in cardiomyocytes via the reactive oxygen species-dependent pyroptotic pathway. | Li S et al. | — | 2021 | → |
| Lipopolysaccharide induces vascular endothelial cell pyroptosis via the SP1/RCN2/ROS signaling pathway. | Zhao J et al. | — | 2021 | → |
| Low Maternal Dietary Intake of Choline Regulates Toll-Like Receptor 4 Expression Via Histone H3K27me3 in Fetal Mouse Neural Progenitor Cells. | Guan X et al. | — | 2021 | → |
| Migraine and neuroinflammation: the inflammasome perspective. | Kursun O et al. | — | 2021 | → |
| MiR-599 Protects Cardiomyocytes against Oxidative Stress-Induced Pyroptosis. | Fan X et al. | — | 2021 | → |
| Mitochondrial Contributions to Hematopoietic Stem Cell Aging. | Morganti C et al. | — | 2021 | → |
| Mitochondrial Dysfunction in Chronic Respiratory Diseases: Implications for the Pathogenesis and Potential Therapeutics. | Zhou WC et al. | — | 2021 | → |
| Neuroimmune and Mu-Opioid Receptor Alterations in the Mesocorticolimbic System in a Sex-Dependent Inflammatory Pain-Induced Alcohol Relapse-Like Rat Model. | Cuitavi J et al. | — | 2021 | → |
| Neuroinflammatory contribution of microglia and astrocytes in fetal alcohol spectrum disorders. | Kane CJM et al. | — | 2021 | → |
| Roles of PRR-Mediated Signaling Pathways in the Regulation of Oxidative Stress and Inflammatory Diseases. | Li P et al. | — | 2021 | → |
| Synthesis and Biological Evaluation of Benzimidazole Derivatives as Potential Neuroprotective Agents in an Ethanol-Induced Rodent Model. | Imran M et al. | — | 2021 | → |
| Taohuajing reduces oxidative stress and inflammation in diabetic cardiomyopathy through the sirtuin 1/nucleotide-binding oligomerization domain-like receptor protein 3 pathway. | Yao R et al. | — | 2021 | → |
| Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases. | Wu AG et al. | — | 2021 | → |
| The emerging roles of absent in melanoma 2 (AIM2) inflammasome in central nervous system disorders. | Li YK et al. | — | 2021 | → |
| The Influence of Mitochondrial-DNA-Driven Inflammation Pathways on Macrophage Polarization: A New Perspective for Targeted Immunometabolic Therapy in Cerebral Ischemia-Reperfusion Injury. | Yu S et al. | — | 2021 | → |
| The Role of Mitochondria in Immune-Cell-Mediated Tissue Regeneration and Ageing. | Su YJ et al. | — | 2021 | → |
| Toll-like receptors in neuroinflammation, neurodegeneration, and alcohol-induced brain damage. | Pascual M et al. | — | 2021 | → |
| Tumor necrosis factor-alpha and interferon-gamma induce inflammasome-mediated corneal endothelial cell death. | Gomez A et al. | — | 2021 | → |
| Uncoupling Protein 2 Deficiency Enhances NLRP3 Inflammasome Activation Following Hyperglycemia-Induced Exacerbation of Cerebral Ischemia and Reperfusion Damage In Vitro and In Vivo. | Zhang T et al. | — | 2021 | → |
| Uric acid drives intestinal barrier dysfunction through TSPO-mediated NLRP3 inflammasome activation. | Lv Q et al. | — | 2021 | → |
| Vitamin D3 ameliorates nitrogen mustard-induced cutaneous inflammation by inactivating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway. | Dong X et al. | — | 2021 | → |
| A novel danshensu derivative ameliorates experimental colitis by modulating NADPH oxidase 4-dependent NLRP3 inflammasome activation. | Pan LL et al. | — | 2020 | → |
| Bibliometric Analysis of the Inflammasome and Pyroptosis in Brain. | Chen Y et al. | — | 2020 | → |
| Cannabinoid 1 Receptor Antagonists Play a Neuroprotective Role in Chronic Alcoholic Hippocampal Injury Related to Pyroptosis Pathway. | Zhang D et al. | — | 2020 | → |
| Chronic ethanol exposure induces neuroinflammation in H4 cells through TLR3 / NF-κB pathway and anxiety-like behavior in male C57BL/6 mice. | Wang X et al. | — | 2020 | → |
| Daily alcohol intake triggers aberrant synaptic pruning leading to synapse loss and anxiety-like behavior. | Socodato R et al. | — | 2020 | → |
| Down-regulation of CRTAC1 attenuates UVB-induced pyroptosis in HLECs through inhibiting ROS production. | Sun Y et al. | — | 2020 | → |
| Elamipretide Attenuates Pyroptosis and Perioperative Neurocognitive Disorders in Aged Mice. | Zuo Y et al. | — | 2020 | → |
| Ethanol-activated CaMKII signaling induces neuronal apoptosis through Drp1-mediated excessive mitochondrial fission and JNK1-dependent NLRP3 inflammasome activation. | Lim JR et al. | — | 2020 | → |
| Fiery Cell Death: Pyroptosis in the Central Nervous System. | McKenzie BA et al. | — | 2020 | → |
| Genistein Attenuates Acute Cerebral Ischemic Damage by Inhibiting the NLRP3 Inflammasome in Reproductively Senescent Mice. | Wang S et al. | — | 2020 | → |
| Gonadal Hormones E2 and P Mitigate Cerebral Ischemia-Induced Upregulation of the AIM2 and NLRC4 Inflammasomes in Rats. | Habib P et al. | — | 2020 | → |
| Impairment of the autophagy-lysosomal pathway and activation of pyroptosis in macular corneal dystrophy. | Zheng T et al. | — | 2020 | → |
| Mitochondria as a therapeutic target for ischemic stroke. | He Z et al. | — | 2020 | → |
| Murine Models for the Study of Fetal Alcohol Spectrum Disorders: An Overview. | Almeida L et al. | — | 2020 | → |
| NLRP3 Inflammasome and Inflammatory Diseases. | Wang Z et al. | — | 2020 | → |
| Nutrients and Immunometabolism: Role of Macrophage NLRP3. | Claycombe-Larson KJ et al. | — | 2020 | → |
| Riding the tiger - physiological and pathological effects of superoxide and hydrogen peroxide generated in the mitochondrial matrix. | Brand MD | — | 2020 | → |
| Role of Inflammasomes in HIV-1 and Drug Abuse Mediated Neuroinflammaging. | Sil S et al. | — | 2020 | → |
| The intrinsic and extrinsic elements regulating inflammation. | Mollaei M et al. | — | 2020 | → |
| The role of astrocytes in oxidative stress of central nervous system: A mixed blessing. | Chen Y et al. | — | 2020 | → |
| The Roles of Endoplasmic Reticulum in NLRP3 Inflammasome Activation. | Zhou Y et al. | — | 2020 | → |
| Acinetobacter baumannii outer membrane protein 34 elicits NLRP3 inflammasome activation via mitochondria-derived reactive oxygen species in RAW264.7 macrophages. | An Z et al. | — | 2019 | → |
| ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation. | Cao R et al. | — | 2019 | → |
| Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis. | Sun YB et al. | — | 2019 | → |
| Elevated Levels of NLRP3 in Cerebrospinal Fluid of Patients With Autoimmune GFAP Astrocytopathy. | Luo Y et al. | — | 2019 | → |
| Enhanced Subcellular Trafficking of Resveratrol Using Mitochondriotropic Liposomes in Cancer Cells. | Kang JH et al. | — | 2019 | → |
| Excessive Iodine Promotes Pyroptosis of Thyroid Follicular Epithelial Cells in Hashimoto's Thyroiditis Through the ROS-NF-κB-NLRP3 Pathway. | Liu J et al. | — | 2019 | → |
| Exosomes Mediate Hippocampal and Cortical Neuronal Injury Induced by Hepatic Ischemia-Reperfusion Injury through Activating Pyroptosis in Rats. | Zhang L et al. | — | 2019 | → |
| HMGB1-induced endothelial cell pyroptosis is involved in systemic inflammatory response syndrome following radiofrequency ablation of hepatic hemangiomas. | Yang M et al. | — | 2019 | → |
| IL-1β expression is increased and regulates GABA transmission following chronic ethanol in mouse central amygdala. | Patel RR et al. | — | 2019 | → |
| Manganese activates NLRP3 inflammasome signaling and propagates exosomal release of ASC in microglial cells. | Sarkar S et al. | — | 2019 | → |
| Mitochondrial ROS promote macrophage pyroptosis by inducing GSDMD oxidation. | Wang Y et al. | — | 2019 | → |
| Nebivolol Improves Obesity-Induced Vascular Remodeling by Suppressing NLRP3 Activation. | Gao J et al. | — | 2019 | → |
| Neuroimmune signaling in alcohol use disorder. | Erickson EK et al. | — | 2019 | → |
| Nickel induces inflammatory activation via NF-κB, MAPKs, IRF3 and NLRP3 inflammasome signaling pathways in macrophages. | Guo H et al. | — | 2019 | → |
| NLRP3 inflammasome expression in peripheral blood monocytes of coronary heart disease patients and its modulation by rosuvastatin. | Zhu J et al. | — | 2019 | → |
| NLRP3 inflammasome in ischemic stroke: As possible therapeutic target. | Alishahi M et al. | — | 2019 | → |
| Obestatin improve spatial memory impairment in a rat model of fetal alcohol spectrum disorders via inhibiting apoptosis and neuroinflammation. | Toosi A et al. | — | 2019 | → |
| Oxidative stress mediates ethanol-induced skeletal muscle mitochondrial dysfunction and dysregulated protein synthesis and autophagy. | Kumar A et al. | — | 2019 | → |
| The impairment in the NLRP3-induced NO secretion renders astrocytes highly permissive to T. cruzi replication. | Pacheco AL et al. | — | 2019 | → |
| The Potential Role of the NLRP3 Inflammasome Activation as a Link Between Mitochondria ROS Generation and Neuroinflammation in Postoperative Cognitive Dysfunction. | Wei P et al. | — | 2019 | → |
| TLR4 participates in the transmission of ethanol-induced neuroinflammation via astrocyte-derived extracellular vesicles. | Ibáñez F et al. | — | 2019 | → |
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | Scarnati MS et al. | — | 2019 | → |
| A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes. | Jha JC et al. | — | 2018 | → |
| Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists. | Morris G et al. | — | 2018 | → |
| Deep sequencing and miRNA profiles in alcohol-induced neuroinflammation and the TLR4 response in mice cerebral cortex. | Ureña-Peralta JR et al. | — | 2018 | → |
| Distinguishing normal brain aging from the development of Alzheimer's disease: inflammation, insulin signaling and cognition. | Denver P et al. | — | 2018 | → |
| Ethanol and Cytokines in the Central Nervous System. | Roberto M et al. | — | 2018 | → |
| Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke. | Fann DY et al. | — | 2018 | → |
| Inflammasomes: Pandora's box for sepsis. | Kumar V | — | 2018 | → |
| Ketamine induces hippocampal apoptosis through a mechanism associated with the caspase-1 dependent pyroptosis. | Ye Z et al. | — | 2018 | → |
| Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes. | Sarkar S et al. | — | 2018 | → |
| Microglial IL-1β progressively increases with duration of alcohol consumption. | Pradier B et al. | — | 2018 | → |
| Mito-Tempo prevents nicotine-induced exacerbation of ischemic brain damage. | Li C et al. | — | 2018 | → |
| Molecular pathogenesis in chronic obstructive pulmonary disease and therapeutic potential by targeting AMP-activated protein kinase. | Zhang Z et al. | — | 2018 | → |
| NLRs as Helpline in the Brain: Mechanisms and Therapeutic Implications. | Singh S et al. | — | 2018 | → |
| Omega-3 docosahexaenoic acid induces pyroptosis cell death in triple-negative breast cancer cells. | Pizato N et al. | — | 2018 | → |
| Procyanidins attenuate neuropathic pain by suppressing matrix metalloproteinase-9/2. | Pan C et al. | — | 2018 | → |
| Pyroptosis, a novel mechanism implicated in cataracts. | Jin X et al. | — | 2018 | → |
| Pyroptosis in pterygium pathogenesis. | Sun N et al. | — | 2018 | → |
| The Possibility and Molecular Mechanisms of Cell Pyroptosis After Cerebral Ischemia. | Dong Z et al. | — | 2018 | → |
| The role of mitochondria in NLRP3 inflammasome activation. | Liu Q et al. | — | 2018 | → |
| TLR4-MyD88 pathway promotes the imbalanced activation of NLRP3/NLRP6 via caspase-8 stimulation after alkali burn injury. | Chen H et al. | — | 2018 | → |
| Autophagy and inflammation. | Qian M et al. | — | 2017 | → |
| FABP4/aP2 Regulates Macrophage Redox Signaling and Inflammasome Activation via Control of UCP2. | Steen KA et al. | — | 2017 | → |
| Inflammasome in drug abuse. | Xu E et al. | — | 2017 | → |
| Memantine Can Reduce Ethanol-Induced Caspase-3 Activity and Apoptosis in H4 Cells by Decreasing Intracellular Calcium. | Wang X et al. | — | 2017 | → |
| Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson's disease. | Sarkar S et al. | — | 2017 | → |
| Nanoporous microstructures mediate osteogenesis by modulating the osteo-immune response of macrophages. | Chen Z et al. | — | 2017 | → |
| Nano-sized iron particles may induce multiple pathways of cell death following generation of mistranscripted RNA in human corneal epithelial cells. | Park EJ et al. | — | 2017 | → |
| Nanotopography-based strategy for the precise manipulation of osteoimmunomodulation in bone regeneration. | Chen Z et al. | — | 2017 | → |
| New Implications for the Melanocortin System in Alcohol Drinking Behavior in Adolescents: The Glial Dysfunction Hypothesis. | Orellana JA et al. | — | 2017 | → |
| NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies. | Song L et al. | — | 2017 | → |
| Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation. | Jiang S et al. | — | 2017 | → |
| Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease. | Yamamoto S et al. | — | 2017 | → |
| Role of pattern recognition receptors of the neurovascular unit in inflamm-aging. | Wilhelm I et al. | — | 2017 | → |
| The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation. | Hashimoto M et al. | — | 2017 | → |
| Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review). | Kawaratani H et al. | — | 2017 | → |
| Trimethylamine-N-Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3-SOD2-mtROS Signaling Pathway. | Chen ML et al. | — | 2017 | → |
| Alum: an old dog with new tricks. | Wen Y et al. | — | 2016 | → |
| Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages. | Zhang H et al. | — | 2016 | → |
| Cadmium induces NLRP3 inflammasome-dependent pyroptosis in vascular endothelial cells. | Chen H et al. | — | 2016 | → |
| CdSe/ZnS quantum dots induce hepatocyte pyroptosis and liver inflammation via NLRP3 inflammasome activation. | Lu Y et al. | — | 2016 | → |
| Ethanol and Other Short-Chain Alcohols Inhibit NLRP3 Inflammasome Activation through Protein Tyrosine Phosphatase Stimulation. | Hoyt LR et al. | — | 2016 | → |
| Ethanol-Induced TLR4/NLRP3 Neuroinflammatory Response in Microglial Cells Promotes Leukocyte Infiltration Across the BBB. | Alfonso-Loeches S et al. | — | 2016 | → |
| Ethanol-mediated activation of the NLRP3 inflammasome in iPS cells and iPS cells-derived neural progenitor cells. | De Filippis L et al. | — | 2016 | → |
| Homocysteine, Liver Function Derangement and Brain Atrophy in Alcoholics. | Fernández-Rodríguez C et al. | — | 2016 | → |
| Impact of the Innate Immune Response in the Actions of Ethanol on the Central Nervous System. | Montesinos J et al. | — | 2016 | → |
| Inflammasomes link vascular disease with neuroinflammation and brain disorders. | Lénárt N et al. | — | 2016 | → |
| Mitochondrial dysfunction in inflammatory responses and cellular senescence: pathogenesis and pharmacological targets for chronic lung diseases. | Yue L et al. | — | 2016 | → |
| NLRP3 Inflammasome Activation in the Brain after Global Cerebral Ischemia and Regulation by 17<i>β</i>-Estradiol. | Thakkar R et al. | — | 2016 | → |
| NOD-Like Receptor Protein 3 Inflammasome Priming and Activation in Barrett's Epithelial Cells. | Nadatani Y et al. | — | 2016 | → |
| Probenecid protects against oxygen-glucose deprivation injury in primary astrocytes by regulating inflammasome activity. | Jian Z et al. | — | 2016 | → |
| Putting the Pieces Together: NOD-Like Receptor Protein 3 Inflammasome Priming and Activation in Barrett's Epithelial Cells. | Andl CD | — | 2016 | → |
| The anti-inflammatory effects of baicalin through suppression of NLRP3 inflammasome pathway in LPS-challenged piglet mononuclear phagocytes. | Ye C et al. | — | 2016 | → |
| The neuroimmune transcriptome and alcohol dependence: potential for targeted therapies. | Warden A et al. | — | 2016 | → |
| Virulent Mycobacterium bovis Beijing Strain Activates the NLRP7 Inflammasome in THP-1 Macrophages. | Zhou Y et al. | — | 2016 | → |
| Chronic ethanol exposure combined with high fat diet up-regulates P2X7 receptors that parallels neuroinflammation and neuronal loss in C57BL/6J mice. | Asatryan L et al. | — | 2015 | → |
| Coenzyme Q10 protects astrocytes from ROS-induced damage through inhibition of mitochondria-mediated cell death pathway. | Jing L et al. | — | 2015 | → |
| Differential expression of inflammasomes in lung cancer cell lines and tissues. | Kong H et al. | — | 2015 | → |
| Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. | Yan Y et al. | — | 2015 | → |
| Editorial: Mechanisms of neuroinflammation and inflammatory neurodegeneration in acute brain injury. | Liesz A et al. | — | 2015 | → |
| Nanoparticle-Based and Bioengineered Probes and Sensors to Detect Physiological and Pathological Biomarkers in Neural Cells. | Maysinger D et al. | — | 2015 | → |
| Carbon black and titanium dioxide nanoparticles induce distinct molecular mechanisms of toxicity. | Boland S et al. | — | 2014 | → |